A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment

Tyring, SK; Rosen, T; Berman, B; Stasko, N; Durham, T; Maeda-Chubachi, T

Maeda-Chubachi, T (reprint author), Novan Inc, Morrisville, NC 27560 USA.

JOURNAL OF DRUGS IN DERMATOLOGY, 2018; 17 (10): 1100

Abstract

Background: Nitric oxide (NO), a free radical gas, is endogenously produced in human cells. In high concentration, NO neutralizes many disease-causing......

Full Text Link